ABERDEEN STD GOLD ETF TR's ticker is SGOL and the CUSIP is 00326A104. A total of 222 filers reported holding ABERDEEN STD GOLD ETF TR in Q4 2020. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $237,771 | -3.7% | 13,441 | 0.0% | 0.03% | +3.8% |
Q2 2023 | $246,911 | -12.7% | 13,441 | -17.0% | 0.03% | -3.7% |
Q4 2022 | $282,752 | +18.8% | 16,185 | +8.2% | 0.03% | -3.6% |
Q3 2022 | $238,000 | -29.4% | 14,961 | -23.0% | 0.03% | -15.2% |
Q2 2022 | $337,000 | -99.9% | 19,421 | -14.4% | 0.03% | -5.7% |
Q1 2022 | $421,302,000 | +59.5% | 22,675 | +50.8% | 0.04% | +66.7% |
Q4 2021 | $264,102,000 | +10.8% | 15,040 | +6.4% | 0.02% | 0.0% |
Q3 2021 | $238,259,000 | +107709.5% | 14,140 | +8.6% | 0.02% | -25.0% |
Q2 2021 | $221,000 | -8.7% | 13,020 | -11.7% | 0.03% | +7.7% |
Q1 2021 | $242,000 | -13.6% | 14,740 | -3.9% | 0.03% | -25.7% |
Q4 2020 | $280,000 | -1.4% | 15,340 | 0.0% | 0.04% | -7.9% |
Q3 2020 | $284,000 | -3.4% | 15,340 | -10.7% | 0.04% | -20.8% |
Q2 2020 | $294,000 | +6.9% | 17,180 | -5.5% | 0.05% | -17.2% |
Q1 2020 | $275,000 | -4.2% | 18,180 | -7.6% | 0.06% | +18.4% |
Q4 2019 | $287,000 | +23.2% | 19,680 | +953.5% | 0.05% | -21.0% |
Q1 2019 | $233,000 | – | 1,868 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mountain Lake Investment Management LLC | 715,000 | $12,491,050 | 9.49% |
STAPP WEALTH MANAGEMENT, PLLC | 151,197 | $2,642 | 6.33% |
Ameliora Wealth Management Ltd. | 483,191 | $8,441,347 | 4.52% |
Empirical Asset Management, LLC | 228,797 | $3,997,084 | 4.21% |
MILESTONE ASSET MANAGEMENT, LLC | 322,836 | $5,969,238 | 3.55% |
Cypress Capital, LLC | 599,156 | $10,467,255 | 3.46% |
BOS Asset Management, LLC | 208,270 | $3,638,477 | 3.25% |
WT Wealth Management | 366,761 | $6,407,316 | 3.11% |
Newman Dignan & Sheerar, Inc. | 537,044 | $9,382,159 | 3.11% |
Ethos Financial Group, LLC | 510,399 | $8,914,592 | 3.02% |